SCHEMBL5636971

SCHEMBL5636971

O=C(NCCO)c1ccc(F)cc1F

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.55
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
CES2 O00748 1/20 0.53
CES1 P23141 1/20 0.53
HDAC3 O15379 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.49
MAP2K2 P36507 1/20 0.48
MAP2K1 Q02750 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
BCL3 P20749 1/20 0.47
SNCA P37840 1/20 0.47
ACKR3 P25106 1/20 0.46
KMT2A Q03164 1/20 0.46
ESRRG P62508 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12462063 0.86 HDAC3 (0.54) NPC1RAB9ACES2CES1HDAC3
SCHEMBL13753140 0.85 L3MBTL1 (0.54) NPC1RAB9ACES2CES1HDAC3
SCHEMBL19835910 0.83 CDK1 (0.54) ALPLNPC1RAB9AL3MBTL1MAP2K2
SCHEMBL14243219 0.83 SMN1; SMN2 (0.50) NPC1RAB9AMAP2K2MAP2K1KDM4E
SCHEMBL17950994 0.83 GCG (0.54) NPC1RAB9ACES2CES1HDAC3
SCHEMBL4510569 0.83 TMEM97 (0.58) NPC1RAB9AMAP2K2MAP2K1KDM4E
SCHEMBL7967927 0.82 NPC1 (0.50) NPC1RAB9ACES2CES1HDAC3
SCHEMBL21210764 0.82 HTT (0.58) NPC1RAB9ACES2CES1HDAC3
SCHEMBL8980561 0.81 KDM4E (0.58) ALPLKDM4EALDH1A1MAPTCASP1
SCHEMBL14743123 0.81 MAP2K2 (0.47) ALPLNPC1RAB9AMAP2K2MAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39679-E1 Substituted heterocycle fused gamma-carbolines BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-06-05 US disclosed
EP-1192165-B1 SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-09-22 EP disclosed
US-6713471-B1 SUCH AS TERT-BUTYL-1-METHYL-6,7,9,12-TETRAHYDRO-5H-PYRIDO-(4,3-B)(1,4) THIAZEPINO(2,3,4-HI)INDOLE-11(10H)-CARBOXYLATE; SEROTONIN AGONISTS AND ANTAGONISTS; CENTRAL NERVOUS SYSTEM DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-03-30 US disclosed